Bioceres Crop Solutions Corp. BIOX 深 滬
已收盤 02-06 16:00:00 美东时间
0.5651
+0.032
+6.00%
華盛通- 最 高0.6004
- 今 開0.548
- 成交量 70.36万股
- 最 低 0.534
- 昨 收 0.5331
- 總市值 3587.19万
- 52周最高 5.40
- 市盈率 靜 --
- 換手率 1.11%
- 52周最低 0.5289
- 委 比 89.64%
- 總股本 6347.88万
- 歷史最高 17.94
- 量 比 0.36
- 振 幅 12.46%
- 歷史最低 0.5289
- 每 手 1
- 風險率 1.46%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 杰富瑞上调百度目标价从159美元升至181美元；花旗下调京东目标价从44美元下调至37美元
今日重点评级关注：Ascendiant Capital：维持NRX Pharmaceuticals"买入"评级，目标价从47美元升至48美元；BTIG：维持Hudson Pacific Properties"买入"评级，目标价从4.75美元升至26美元
01-05 13:52
Ulta Beauty To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday
Top Wall Street analysts changed their outlook on these top names. For a comple...
01-02 21:26
Canaccord Genuity Maintains Hold on Bioceres Crop Solutions, Lowers Price Target to $2
Canaccord Genuity analyst Austin Moeller maintains Bioceres Crop Solutions (NASDAQ:BIOX) with a Hold and lowers the price target from $2.25 to $2.
01-02 21:04
美股大行评级 | 花旗上调Bilibili目标价升至27美元； 摩根士丹利上调英伟达目标价升至220美元；Ardent Health、Stubhub遭多家大行下调评级
花旗上调Bilibili目标价升至27美元； 摩根士丹利上调英伟达目标价升至220美元；Ardent Health、Stubhub遭多家大行下调评级>>
2025-11-17 10:49
Canaccord Genuity Maintains Hold on Bioceres Crop Solutions, Lowers Price Target to $2.25
Canaccord Genuity analyst Austin Moeller maintains Bioceres Crop Solutions (NASDAQ:BIOX) with a Hold and lowers the price target from $2.5 to $2.25.
2025-11-15 01:39
Bioceres Crop Solutions Q1 EPS $(0.12) Misses $(0.07) Estimate, Sales $77.300M Miss $90.225M Estimate
Bioceres Crop Solutions (NASDAQ:BIOX) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.07) by 66.67 percent. This is a 50 percent decrease over losses of $(0.08) per share
2025-11-13 06:33
美股大行评级 | 最高400美元！大行纷纷连夜上调甲骨文目标价；新思科技则惨遭多家大行下调目标价
今日重点评级关注：瑞银：上调Gossamer Bio评级至"买入"，目标价从1.25美元升至9美元；Canaccord Genuity：维持Corcept Therapeutics"买入"评级，目标价从137美元升至140美元
2025-09-11 10:06
Canaccord Genuity Downgrades Bioceres Crop Solutions to Hold, Lowers Price Target to $2.5
Canaccord Genuity analyst Austin Moeller downgrades Bioceres Crop Solutions (NASDAQ:BIOX) from Buy to Hold and lowers the price target from $6.5 to $2.5.
2025-09-10 18:17
Bioceres Crop Solutions Faces Challenging Fiscal Year
Bioceres Crop Solutions ( ($BIOX) ) has released its Q4 earnings. Here is a bre...
2025-09-10 11:53
12 Materials Stocks Moving In Tuesday's Intraday Session
Gainers Bon Natural Life (NASDAQ:BON) stock rose 16.2% to $1.79 during Tuesday...
2025-09-10 01:06
